Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro
about
sameAs
Interferons, interferon-like cytokines, and their receptorsImmunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses.Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients.Host genetic variations are associated with virological response to interferon therapy of chronic HCV in Han Chinese patients.Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.Host genetic determinants in hepatitis C virus infection.The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer.Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B.Molecular cloning, polymorphism, and functional activity of the bovine and water buffalo Mx2 gene promoter regionThe interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment.Polymorphisms in the promoter region of the porcine antiviral MX1 and MX2 genes.Functional characterization of new allelic polymorphisms identified in the promoter region of the human MxA gene.Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.Myxovirus resistance 1 gene polymorphisms and outcomes of viral hepatitis B and C infections in Moroccan patients.Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel.Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection.Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics.Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.MxA transcripts with distinct first exons and modulation of gene expression levels by single-nucleotide polymorphisms in human bronchial epithelial cells.Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.Myxovirus resistance protein A (MxA) polymorphism is associated with IFNβ response in Iranian multiple sclerosis patients.Influence of MX1 promoter rs2071430 G/T polymorphism on susceptibility to systemic lupus erythematosus.
P2860
Q28293630-2030F451-F6D4-4775-B9E8-DBB46B5B228EQ30409873-0E814BCF-3F5A-49CE-B152-12E9D80B8FBFQ33249075-53C155E4-2535-4B7B-96AF-1C8AC338D682Q34040606-34B9C41A-3FD5-4EC2-B469-E13262EFEF76Q34604371-091881E4-E2BC-4480-A2DA-1F2647C41104Q35740155-E0308B80-3C31-43E4-8F65-A5E580D649A6Q35753723-720B1E54-E034-402A-8737-FFEEC07ADF2DQ36892193-C435A1EA-28DF-410E-8500-157199C48B06Q37028594-DC56503C-DD71-40F7-8416-42CD3BE502BDQ37234172-D99610F6-4149-40EE-87BA-DB566F889CA1Q37528418-242E2C3C-BFE5-4B68-941C-4334FA483224Q37997042-8E0663AC-E16F-42DC-8603-05BCD7C1EEE3Q38293815-44D82AE8-8904-4140-98B4-4D7713153354Q39277224-E200F2FF-C1F2-446E-8DA1-A8DB3743E428Q39450473-0FB38C82-9D3A-49FB-98F5-9AEB46DB6D21Q40599607-A60746BA-F7CC-41BF-862F-FBA640C329A5Q41276123-8ADF63E7-C8CC-4780-B506-A724FC4E3C86Q42265407-C8BF922D-C972-45B5-9E3A-B7F14C555E11Q42731526-FEF68F68-5358-4F11-99EB-C1BBEA2400FDQ43046800-48D39DF8-A605-4618-B519-1892DCD29DAEQ43836592-5FB945A5-D77B-4384-8C8F-B1C79B713DF8Q47675220-CF8C39F0-EF19-4220-A63A-2DF238F62B6DQ51068027-38FC51C4-3EE7-4347-A164-5E8031359A64Q53799932-B4C46BB4-F60F-4BBC-A8D9-81616F63C1E6
P2860
Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro
description
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
scientific article (publication date: 2001)
@en
vedecký článok (publikovaný 2001)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd in 2001)
@nl
наукова стаття, опублікована у 2001
@uk
مقالة علمية (نشرت عام 2001)
@ar
name
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@ast
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@en
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@nl
type
label
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@ast
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@en
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@nl
prefLabel
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@ast
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@en
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@nl
P2093
P356
P1433
P1476
Genetic polymorphism of the Mx ...... and -88) in vivo and in vitro
@en
P2093
P304
P356
10.1159/000050075
P407
P577
2001-01-01T00:00:00Z